(Q72623688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Depression vulnerability and 5-hydroxytryptophan prophylaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

H. van Praag

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6160599

17 August 2023

S. de Hann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6160599

17 August 2023

language of work or name

English

0 references

publication date

1 September 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://api.elsevier.com/content/article/PII:0165178180900499?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

https://api.elsevier.com/content/article/PII:0165178180900499?httpAccept=text/plain

17 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

17 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

75-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

27 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Biochemical post-mortem findings in depressed patients

17 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Norepinephrine in depressive reactions. A review

17 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.

17 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

17 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.

17 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

L-5-HTP Treatment and Serum 5-HT Level after L-5-HTP Loading on Depressed Patients

17 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Decarboxylation of exogenous L-5-hydroxytryptophan after destruction of the cerebral raphe system.

17 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

17 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

17 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Release of [3H]dopamine byl-5-hydroxytryptophan

17 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

New evidence of serotonin-deficient depressions

17 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Central monoamine metabolism in depressions. I. Serotonin and related compounds

17 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

5-Hydroxytryptophan in combination with clomipramine in “therapy-resistant” depressions

17 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Central serotonin metabolism and frequency of depression

17 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

17 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

17 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

17 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Cerebral monoamines and depression. An investigation with the Probenecid technique.

17 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex

17 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part 1: Implications of reproducible mood elevation

17 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique

17 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

The catecholamine hypothesis of affective disorders: a review of supporting evidence

17 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis

17 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Mode of action of antidepressant drugs

17 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Letter: L 5-Hydroxytryptophan and mood

17 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

17 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90049-9

17 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6160599%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference